Dynamic Technology Lab Private LTD Regenxbio Inc. Transaction History

Dynamic Technology Lab Private LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$11.51 - $21.53 $368,343 - $689,003	32,002 Added 188.78%	48,954 $573,000
Q1 2024 May 14, 2024	BUY	$12.17 - $24.61 $206,305 - $417,188	16,952 New	16,952 $357,000
Q1 2023 May 12, 2023	BUY	$18.08 - $24.55 $343,321 - $466,179	18,989 Added 185.26%	29,239 $553,000
Q4 2022 Feb 13, 2023	SELL	$20.4 - $24.73 $160,548 - $194,625	-7,870 Reduced 43.43%	10,250 $232,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $403,894 - $634,924	18,120 New	18,120 $479,000
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $471,366 - $665,411	-11,223 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$40.82 - $62.45 $458,122 - $700,876	11,223 New	11,223 $643,000
Q1 2018 May 14, 2018	SELL	$24.05 - $37.5 $281,649 - $439,162	-11,711 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$26.0 - $34.6 $60,684 - $80,756	-2,334 Reduced 16.62%	11,711 $390,000
Q3 2017 Nov 08, 2017	BUY	$18.0 - $32.95 $252,810 - $462,782	14,045	14,045 $463,000

193

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $344M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.